Umpqua Bank Raises Share Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Umpqua Bank boosted its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 3.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,412 shares of the medical conglomerate’s stock after purchasing an additional 184 shares during the period. UnitedHealth Group makes up about 1.1% of Umpqua Bank’s investment portfolio, making the stock its 20th largest position. Umpqua Bank’s holdings in UnitedHealth Group were worth $2,756,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Macroview Investment Management LLC grew its position in UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares during the period. Delos Wealth Advisors LLC boosted its holdings in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares during the period. True Wealth Design LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at about $31,000. Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the second quarter valued at about $31,000. Finally, Signature Resources Capital Management LLC boosted its position in shares of UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 , after buying another 18 shares during that period. Hedge funds and other institutional investors own 87.86% of the company’s shares.

UnitedHealth Group stock rose 0.2%

Shares of NYSE:UNH opened at $596.88 on Friday. The firm has a 50-day simple moving average of $558.98 and a 200-day simple moving average of $515.11. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94. The company has a current ratio of 0.88, a quick ratio of 0.88, and a debt-to-equity ratio of 0.67. The company has a market cap of $549.36 billion, a PE ratio of 36.48, a P/E/G ratio of 1.68 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH – Get Free Report ) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company’s quarterly revenue was up 6.4% year over year. During the same period in the prior year, the business earned $6.14 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group announces dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a dividend of $2.10 per share. This represents an annualized dividend of $8.40 and a yield of 1.41%. The ex-dividend date is Monday, September 16. UnitedHealth Group’s payout ratio is currently 51.34%.

Changes in Analyst Ratings

Several research analysts recently commented on UNH shares. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research report on Monday, August 19th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price target for the company from $481.00 to $647.00 in a research report on Wednesday, May 17 July. Truist Financial boosted their price objective on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Wells Fargo & Company upped their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Finally, TD Cowen boosted their price objective on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $614.17.

Read our latest stock report on UNH

Indoor activity

In related news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible via this hyperlink. In related news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The sale was disclosed in a legal filing with the SEC, which is available on the SEC’s website. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s shares.

UnitedHealth Group Company Profile

(Free report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment provides consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; health care coverage and health and wellness services for people age 50 and older that address their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits and hospital and clinic services, and health care products and services for state care programs for the economically disadvantaged, medically underserved, and those without funded health care coverage by employer.

Featured stories

Want to see what other hedge funds own UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Get daily news and ratings for UnitedHealth Group – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.